肿瘤细胞治疗研究
ALL SOURCES
Integrated microfluidics-based construction of anti-BTN2A2 gel droplet cell preparations for non-invasive tumor-infiltrating lymphocyte therapy.
TIL（肿瘤浸润淋巴细胞）疗法（TIL 疗法）是实体瘤的有效治疗手段之一。
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal a
在 4-1BB 和 CD3 激动作用的辅助下制备的 TIL 是可行的，且治疗未伴随新的安全性信号。
Targeting intratumoral heterogeneity in pancreatic cancer with sequential TIL infusions.
TIL（肿瘤浸润淋巴细胞）的过继转移在黑色素瘤和部分实体瘤中有效，但其在胰腺导管腺癌（PDAC）中的潜力仍基本未被探索。
Expansion of KRAS hotspot mutations reactive T cells from human pancreatic tumors using autologous T cells as the antigen-presenting cells.
针对突变KRAS的ACT在实现PDAC持久临床缓解方面具有巨大潜力，而PDAC在过去40年中一直没有实质性改善。
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
